Influence of an acidic beverage on the absorption of erlotinib

Trial Profile

Influence of an acidic beverage on the absorption of erlotinib

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 May 2016

At a glance

  • Drugs Erlotinib (Primary) ; Omeprazole
  • Indications Lung cancer
  • Focus Pharmacokinetics
  • Acronyms COLA
  • Most Recent Events

    • 08 Feb 2016 Results published in the Journal of Clinical Oncology
    • 24 Dec 2015 Status changed from recruiting to completed as per Netherlands Trial Register record.
    • 26 Jun 2015 Planned number of patients changed from 36 to 28 as per Netherlands Trial Register record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top